Patent · US Active

Polymorphic and hydrate forms, salts and process for preparing 6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline

US8629144B2 · kind B2 · utility

0Cited by

5References

19Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Tom Cornelis Hortense Govaerts · Betekom, BE
Johan Erwin Edmond Weerts · Beerse, BE
Carina Leys · Stabroek, BE
Julius Walter Jozef Dickens · Beerse, BE
Sigrid Carl Maria Stokbroekx · Beerse, BE

Key dates

Filing date	Jun 19, 2008
Grant date	Jan 14, 2014
Priority date	—
Expiry date	Aug 31, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel polymorphic and hydrate forms and salts of 6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline, to methods for their preparation, to pharmaceutical compositions comprising at least one of said polymorphic or hydrate forms or salts, and to the therapeutic and/or prophylactic use of such compositions. The invention also provides new manners for preparing said compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.